000 01391 a2200373 4500
005 20250512201254.0
264 0 _c19820512
008 198205s 0 0 eng d
022 _a0022-3573
024 7 _a10.1111/j.2042-7158.1982.tb04681.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpedding, M
245 0 0 _aStereospecific blockade of alpha 2-adrenoceptors by (+)-butaclamol: implications for the characterization of dopamine receptors.
_h[electronic resource]
260 _bThe Journal of pharmacy and pharmacology
_cJan 1982
300 _a56-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdrenergic alpha-Antagonists
650 0 4 _aAnimals
650 0 4 _aButaclamol
_xpharmacology
650 0 4 _aClonidine
_xpharmacology
650 0 4 _aDibenzocycloheptenes
_xpharmacology
650 0 4 _aIn Vitro Techniques
650 0 4 _aMale
650 0 4 _aMuscle Contraction
_xdrug effects
650 0 4 _aMuscle, Smooth, Vascular
_xdrug effects
650 0 4 _aPhenylephrine
_xantagonists & inhibitors
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aReceptors, Dopamine
_xdrug effects
650 0 4 _aStereoisomerism
700 1 _aBerg, C
773 0 _tThe Journal of pharmacy and pharmacology
_gvol. 34
_gno. 1
_gp. 56-8
856 4 0 _uhttps://doi.org/10.1111/j.2042-7158.1982.tb04681.x
_zAvailable from publisher's website
999 _c6174770
_d6174770